MedPath
NMPA Approval

Sulfogaiacol,Pentoxyverine and Promethazine Granules

国药准字H51023919

March 28, 2022

国药准字H51023919

Drug Information

愈酚喷托异丙嗪颗粒

颗粒剂

复方

化学药品

March 28, 2022

Company Information

Applicant Company

中国(四川)自由贸易试验区成都双流西南航空港经济开发区空港二路361号

Manufacturing Company

四川双流西南航空港经济开发区空港二路361号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

愈酚喷托异丙嗪颗粒 - NMPA 批准文号 | MedPath